These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Serum Calcification Propensity and Clinical Events in CKD. Bundy JD; Cai X; Mehta RC; Scialla JJ; de Boer IH; Hsu CY; Go AS; Dobre MA; Chen J; Rao PS; Leonard MB; Lash JP; Block GA; Townsend RR; Feldman HI; Smith ER; Pasch A; Isakova T; Clin J Am Soc Nephrol; 2019 Nov; 14(11):1562-1571. PubMed ID: 31658949 [TBL] [Abstract][Full Text] [Related]
6. The Effect of Increasing Dialysate Magnesium on Serum Calcification Propensity in Subjects with End Stage Kidney Disease: A Randomized, Controlled Clinical Trial. Bressendorff I; Hansen D; Schou M; Pasch A; Brandi L Clin J Am Soc Nephrol; 2018 Sep; 13(9):1373-1380. PubMed ID: 30131425 [TBL] [Abstract][Full Text] [Related]
7. Blood Calcification Propensity, Cardiovascular Events, and Survival in Patients Receiving Hemodialysis in the EVOLVE Trial. Pasch A; Block GA; Bachtler M; Smith ER; Jahnen-Dechent W; Arampatzis S; Chertow GM; Parfrey P; Ma X; Floege J Clin J Am Soc Nephrol; 2017 Feb; 12(2):315-322. PubMed ID: 27940458 [TBL] [Abstract][Full Text] [Related]
8. High-Flux Hemodialysis and High-Volume Hemodiafiltration Improve Serum Calcification Propensity. Dekker M; Pasch A; van der Sande F; Konings C; Bachtler M; Dionisi M; Meier M; Kooman J; Canaud B PLoS One; 2016; 11(4):e0151508. PubMed ID: 27064679 [TBL] [Abstract][Full Text] [Related]
9. Calcification Propensity and Survival among Renal Transplant Recipients. Keyzer CA; de Borst MH; van den Berg E; Jahnen-Dechent W; Arampatzis S; Farese S; Bergmann IP; Floege J; Navis G; Bakker SJ; van Goor H; Eisenberger U; Pasch A J Am Soc Nephrol; 2016 Jan; 27(1):239-48. PubMed ID: 25925688 [TBL] [Abstract][Full Text] [Related]
10. Serum Calcification Propensity Is a Strong and Independent Determinant of Cardiac and All-Cause Mortality in Kidney Transplant Recipients. Dahle DO; Åsberg A; Hartmann A; Holdaas H; Bachtler M; Jenssen TG; Dionisi M; Pasch A Am J Transplant; 2016 Jan; 16(1):204-12. PubMed ID: 26375609 [TBL] [Abstract][Full Text] [Related]
11. Serum Calcification Propensity and Fetuin-A: Biomarkers of Cardiovascular Disease in Kidney Transplant Recipients. Bostom A; Pasch A; Madsen T; Roberts MB; Franceschini N; Steubl D; Garimella PS; Ix JH; Tuttle KR; Ivanova A; Shireman T; Gohh R; Merhi B; Jarolim P; Kusek JW; Pfeffer MA; Liu S; Eaton CB Am J Nephrol; 2018; 48(1):21-31. PubMed ID: 29996127 [TBL] [Abstract][Full Text] [Related]
12. Serum calcification propensity is associated with renal tissue oxygenation and resistive index in patients with arterial hypertension or chronic kidney disease. Pruijm M; Lu Y; Megdiche F; Piskunowicz M; Milani B; Stuber M; Bachtler M; Vogt B; Burnier M; Pasch A J Hypertens; 2017 Oct; 35(10):2044-2052. PubMed ID: 28562422 [TBL] [Abstract][Full Text] [Related]
13. Calcification Propensity of Serum is Independent of Excretory Renal Function. Bielesz B; Reiter T; Marculescu R; Gleiss A; Bojic M; Kieweg H; Cejka D Sci Rep; 2017 Dec; 7(1):17941. PubMed ID: 29263429 [TBL] [Abstract][Full Text] [Related]
14. Dialysis initiation improves calcification propensity. Ponte B; Pruijm M; Pasch A; Dufey-Teso A; Martin PY; de Seigneux S Nephrol Dial Transplant; 2020 Mar; 35(3):495-502. PubMed ID: 31738424 [TBL] [Abstract][Full Text] [Related]
15. Biomarkers of vascular calcification and mortality in patients with ESRD. Scialla JJ; Kao WH; Crainiceanu C; Sozio SM; Oberai PC; Shafi T; Coresh J; Powe NR; Plantinga LC; Jaar BG; Parekh RS Clin J Am Soc Nephrol; 2014 Apr; 9(4):745-55. PubMed ID: 24458076 [TBL] [Abstract][Full Text] [Related]
16. Serum Calcification Propensity Represents a Good Biomarker of Vascular Calcification: A Systematic Review. Pluquet M; Kamel S; Choukroun G; Liabeuf S; Laville SM Toxins (Basel); 2022 Sep; 14(9):. PubMed ID: 36136575 [TBL] [Abstract][Full Text] [Related]
17. Acute and 3-month effects of calcium carbonate on the calcification propensity of serum and regulators of vascular calcification: secondary analysis of a randomized controlled trial. Bristow SM; Gamble GD; Pasch A; O'Neill WC; Stewart A; Horne AM; Reid IR Osteoporos Int; 2016 Mar; 27(3):1209-1216. PubMed ID: 26493812 [TBL] [Abstract][Full Text] [Related]
18. Living kidney donation does not adversely affect serum calcification propensity and markers of vascular stiffness. de Seigneux S; Ponte B; Berchtold L; Hadaya K; Martin PY; Pasch A Transpl Int; 2015 Sep; 28(9):1074-80. PubMed ID: 25903063 [TBL] [Abstract][Full Text] [Related]
19. Development of the BioHybrid Assay: Combining Primary Human Vascular Smooth Muscle Cells and Blood to Measure Vascular Calcification Propensity. Jaminon AMG; Akbulut AC; Rapp N; Kramann R; Biessen EAL; Temmerman L; Mees B; Brandenburg V; Dzhanaev R; Jahnen-Dechent W; Floege J; Uitto J; Reutelingsperger CP; Schurgers LJ Cells; 2021 Aug; 10(8):. PubMed ID: 34440866 [TBL] [Abstract][Full Text] [Related]
20. Patients with advanced chronic kidney disease and vascular calcification have a large hydrodynamic radius of secondary calciprotein particles. Chen W; Anokhina V; Dieudonne G; Abramowitz MK; Kashyap R; Yan C; Wu TT; de Mesy Bentley KL; Miller BL; Bushinsky DA Nephrol Dial Transplant; 2019 Jun; 34(6):992-1000. PubMed ID: 29788425 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]